Cyclo Therapeutics's market cap is currently $27.13M. The company's EPS TTM is $-0.895; its P/E ratio is ―; Cyclo Therapeutics is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.08M	$ 1.38M	$ 1.59M	$ 903.38K	$ 1.01M
Gross Profit	$ 977.95K	$ 1.24M	$ 1.43M	$ 836.98K	$ 931.71K
Operating Income	$ -20.05M	$ -15.61M	$ -14.27M	$ -8.96M	$ -7.39M
EBITDA	$ -20.03M	$ -15.60M	$ -14.27M	$ -8.95M	$ -7.39M
Net Income	$ -20.06M	$ -15.28M	$ -14.31M	$ -8.92M	$ -7.67M
Balance Sheet
Cash & Short-Term Investments	$ 9.25M	$ 1.54M	$ 16.61M	$ 12.85M	$ 2.78M
Total Assets	$ 13.25M	$ 4.22M	$ 19.52M	$ 14.19M	$ 4.11M
Total Debt	$ 1.03M	$ 0.00	$ 170.99K	$ 194.44K	$ 52.51K
Net Debt	$ -8.21M	$ -1.54M	$ -16.44M	$ -12.65M	$ -2.73M
Total Liabilities	$ 8.49M	$ 3.48M	$ 3.85M	$ 3.74M	$ 3.18M
Stockholders' Equity	$ 4.76M	$ 734.54K	$ 15.67M	$ 10.45M	$ 935.98K
Cash Flow
Free Cash Flow	$ -16.19M	$ -15.13M	$ -15.03M	$ -8.59M	$ -6.59M
Operating Cash Flow	$ -16.19M	$ -15.11M	$ -15.01M	$ -8.54M	$ -6.59M
Investing Cash Flow	$ -2.42K	$ 38.17K	$ 14.82K	$ -14.05K	$ 36.13K
Financing Cash Flow	$ 23.89M	$ 6.78K	$ 18.76M	$ 18.62M	$ 7.12M

Currency in USD

Cyclo Therapeutics Earnings and Revenue History

Income Statement >

Cyclo Therapeutics Debt to Assets

Balance Sheet >

Cyclo Therapeutics Cash Flow

Cash Flow >

Cyclo Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing